Patent · US Active

Compositions comprising buprenorphine

US9295645B2 · kind B2 · utility

11Cited by

4References

20Claims

0Family size

Assignee

Indivior UK Limited · GB

Inventors

Richard L. Norton · Fort Collins, US
Mingxing Zhou · Fort Collins, US

Key dates

Filing date	Jun 6, 2011
Grant date	Mar 29, 2016
Priority date	—
Expiry date	Sep 16, 2031

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB65B55/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure relates to a buprenorphine sustained release delivery system for treatment of conditions ameliorated by buprenorphine compounds. The sustained release delivery system includes a flowable composition containing a suspension of buprenorphine, a metabolite, or a prodrug thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.